##fileformat=VCFv4.0
##reference=GRCh37/hg19
##INFO=<ID=CADD_SCALED,Number=.,Type=String,Description="na">
##INFO=<ID=RLV_PRESENT,Number=1,Type=String,Description="RLV present">
##INFO=<ID=RLV,Number=.,Type=String,Description="Allele | AlleleFreq | Gene | FDR | Transcript | Phenotype | PhenotypeInheritance | PhenotypeOnset | PhenotypeDetails | PhenotypeGroup | SampleStatus | SamplePhenotype | SampleGenotype | SampleGroup | VariantSignificance | VariantSignificanceSource | VariantSignificanceJustification | VariantCompoundHet | VariantGroup">
##INFO=<ID=RLV_ALLELE,Number=1,Type=String,Description="Allele">
##INFO=<ID=RLV_ALLELEFREQ,Number=1,Type=String,Description="AlleleFreq">
##INFO=<ID=RLV_GENE,Number=1,Type=String,Description="Gene">
##INFO=<ID=RLV_FDR,Number=1,Type=String,Description="FDR">
##INFO=<ID=RLV_TRANSCRIPT,Number=1,Type=String,Description="Transcript">
##INFO=<ID=RLV_PHENOTYPE,Number=1,Type=String,Description="Phenotype">
##INFO=<ID=RLV_PHENOTYPEINHERITANCE,Number=1,Type=String,Description="PhenotypeInheritance">
##INFO=<ID=RLV_PHENOTYPEONSET,Number=1,Type=String,Description="PhenotypeOnset">
##INFO=<ID=RLV_PHENOTYPEDETAILS,Number=1,Type=String,Description="PhenotypeDetails">
##INFO=<ID=RLV_PHENOTYPEGROUP,Number=1,Type=String,Description="PhenotypeGroup">
##INFO=<ID=RLV_SAMPLESTATUS,Number=1,Type=String,Description="SampleStatus">
##INFO=<ID=RLV_SAMPLEPHENOTYPE,Number=1,Type=String,Description="SamplePhenotype">
##INFO=<ID=RLV_SAMPLEGENOTYPE,Number=1,Type=String,Description="SampleGenotype">
##INFO=<ID=RLV_SAMPLEGROUP,Number=1,Type=String,Description="SampleGroup">
##INFO=<ID=RLV_VARIANTSIGNIFICANCE,Number=1,Type=String,Description="VariantSignificance">
##INFO=<ID=RLV_VARIANTSIGNIFICANCESOURCE,Number=1,Type=String,Description="VariantSignificanceSource">
##INFO=<ID=RLV_VARIANTSIGNIFICANCEJUSTIFICATION,Number=1,Type=String,Description="VariantSignificanceJustification">
##INFO=<ID=RLV_VARIANTCOMPOUNDHET,Number=1,Type=String,Description="VariantCompoundHet">
##INFO=<ID=RLV_VARIANTGROUP,Number=1,Type=String,Description="VariantGroup">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
2	47602439	EPCAM:.	G	T	.	.	CADD_SCALED=23.3;RLV_PRESENT=TRUE;RLV=T|8.237E-6|EPCAM|0.006389776357827476 0.0|NM_002354.2|Colorectal cancer  hereditary nonpolyposis  type 8  Diarrhea 5  with tufting enteropathy  congenital|DOMINANT_OR_RECESSIVE|Pediatric|Specific deletions result in MSH2 inactivation  Although Colorectal cancer  hereditary nonpolyposis  type 8 typically manifests in adulthood  individuals have been reported such that familial screening would be recommended to commence during the pediatric period  Diarrhea 5  with tufting enteropathy  congenital may include additional features  such as dysmorphism||SAMPLE:AFFECTED||SAMPLE:0s1||Reported pathogenic|ClinVar|NM_002354.2(EPCAM):c.491+1G>T EPCAM Pathogenic||;RLV_ALLELE=[T|EPCAM]T;RLV_ALLELEFREQ=[T|EPCAM]8.237E-6;RLV_GENE=[T|EPCAM]EPCAM;RLV_FDR=[T|EPCAM]0.006389776357827476 0.0;RLV_TRANSCRIPT=[T|EPCAM]NM_002354.2;RLV_PHENOTYPE=[T|EPCAM]Colorectal cancer  hereditary nonpolyposis  type 8  Diarrhea 5  with tufting enteropathy  congenital;RLV_PHENOTYPEINHERITANCE=[T|EPCAM]DOMINANT_OR_RECESSIVE;RLV_PHENOTYPEONSET=[T|EPCAM]Pediatric;RLV_PHENOTYPEDETAILS=[T|EPCAM]Specific deletions result in MSH2 inactivation  Although Colorectal cancer  hereditary nonpolyposis  type 8 typically manifests in adulthood  individuals have been reported such that familial screening would be recommended to commence during the pediatric period  Diarrhea 5  with tufting enteropathy  congenital may include additional features  such as dysmorphism;RLV_PHENOTYPEGROUP=[T|EPCAM]NA;RLV_SAMPLESTATUS=[T|EPCAM]SAMPLE:AFFECTED;RLV_SAMPLEPHENOTYPE=[T|EPCAM]NA;RLV_SAMPLEGENOTYPE=[T|EPCAM]SAMPLE:0s1;RLV_SAMPLEGROUP=[T|EPCAM]NA;RLV_VARIANTSIGNIFICANCE=[T|EPCAM]Reported pathogenic;RLV_VARIANTSIGNIFICANCESOURCE=[T|EPCAM]ClinVar;RLV_VARIANTSIGNIFICANCEJUSTIFICATION=[T|EPCAM]NM_002354.2(EPCAM):c.491+1G>T EPCAM Pathogenic;RLV_VARIANTCOMPOUNDHET=[T|EPCAM]NA;RLV_VARIANTGROUP=[T|EPCAM]NA
2	47641407	MSH2:.	G	A	.	.	CADD_SCALED=26.7;RLV_PRESENT=TRUE;RLV=A|0.0|MSH2|0.003993610223642172 0.0|NM_000251.2|Colorectal cancer  hereditary nonpolyposis  type 1  Endometrial cancer  Mismatch repair cancer syndrome  Muir-Torre syndrome|DOMINANT_OR_RECESSIVE|Adult (Colorectal cancer  hereditary nonpolyposis  type 1  Endometrial cancer  Muir-Torre syndrome) Pediatric (Mismatch repair cancer syndrome)|Homozygous compound heterozygous mutations have been described in individuals with severe disease  Variants in PMS1 thought to be associated with hereditary colon cancer were found to co-segregate in individuals with MSH2 mutations  Variants may also contribute to cancer susceptibility  and individuals may be at risk for a number of cancer types||SAMPLE:AFFECTED||SAMPLE:0s1||Reported pathogenic|ClinVar|NM_000251.2(MSH2):c.793-1G>A MSH2 Likely pathogenic||;RLV_ALLELE=[A|MSH2]A;RLV_ALLELEFREQ=[A|MSH2]0.0;RLV_GENE=[A|MSH2]MSH2;RLV_FDR=[A|MSH2]0.003993610223642172 0.0;RLV_TRANSCRIPT=[A|MSH2]NM_000251.2;RLV_PHENOTYPE=[A|MSH2]Colorectal cancer  hereditary nonpolyposis  type 1  Endometrial cancer  Mismatch repair cancer syndrome  Muir-Torre syndrome;RLV_PHENOTYPEINHERITANCE=[A|MSH2]DOMINANT_OR_RECESSIVE;RLV_PHENOTYPEONSET=[A|MSH2]Adult (Colorectal cancer  hereditary nonpolyposis  type 1  Endometrial cancer  Muir-Torre syndrome) Pediatric (Mismatch repair cancer syndrome);RLV_PHENOTYPEDETAILS=[A|MSH2]Homozygous compound heterozygous mutations have been described in individuals with severe disease  Variants in PMS1 thought to be associated with hereditary colon cancer were found to co-segregate in individuals with MSH2 mutations  Variants may also contribute to cancer susceptibility  and individuals may be at risk for a number of cancer types;RLV_PHENOTYPEGROUP=[A|MSH2]NA;RLV_SAMPLESTATUS=[A|MSH2]SAMPLE:AFFECTED;RLV_SAMPLEPHENOTYPE=[A|MSH2]NA;RLV_SAMPLEGENOTYPE=[A|MSH2]SAMPLE:0s1;RLV_SAMPLEGROUP=[A|MSH2]NA;RLV_VARIANTSIGNIFICANCE=[A|MSH2]Reported pathogenic;RLV_VARIANTSIGNIFICANCESOURCE=[A|MSH2]ClinVar;RLV_VARIANTSIGNIFICANCEJUSTIFICATION=[A|MSH2]NM_000251.2(MSH2):c.793-1G>A MSH2 Likely pathogenic;RLV_VARIANTCOMPOUNDHET=[A|MSH2]NA;RLV_VARIANTGROUP=[A|MSH2]NA
2	48018065	MSH6:.	G	C	.	.	RLV_PRESENT=TRUE;RLV=C|0.0|MSH6|0.01637380191693291 0.0|NM_000179.2|Colorectal cancer  hereditary nonpolyposis type 5  Mismatch repair cancer syndrome  Endometrial cancer|DOMINANT_OR_RECESSIVE|Adult (Colorectal cancer  hereditary nonpolyposis type 5  Endometrial cancer) Pediatric (Mismatch repair cancer syndrome)|||SAMPLE:AFFECTED||SAMPLE:0s1||Reported pathogenic|ClinVar|NM_000179.2(MSH6):c.261-1G>C MSH6 Likely pathogenic||;RLV_ALLELE=[C|MSH6]C;RLV_ALLELEFREQ=[C|MSH6]0.0;RLV_GENE=[C|MSH6]MSH6;RLV_FDR=[C|MSH6]0.01637380191693291 0.0;RLV_TRANSCRIPT=[C|MSH6]NM_000179.2;RLV_PHENOTYPE=[C|MSH6]Colorectal cancer  hereditary nonpolyposis type 5  Mismatch repair cancer syndrome  Endometrial cancer;RLV_PHENOTYPEINHERITANCE=[C|MSH6]DOMINANT_OR_RECESSIVE;RLV_PHENOTYPEONSET=[C|MSH6]Adult (Colorectal cancer  hereditary nonpolyposis type 5  Endometrial cancer) Pediatric (Mismatch repair cancer syndrome);RLV_PHENOTYPEDETAILS=[C|MSH6]NA;RLV_PHENOTYPEGROUP=[C|MSH6]NA;RLV_SAMPLESTATUS=[C|MSH6]SAMPLE:AFFECTED;RLV_SAMPLEPHENOTYPE=[C|MSH6]NA;RLV_SAMPLEGENOTYPE=[C|MSH6]SAMPLE:0s1;RLV_SAMPLEGROUP=[C|MSH6]NA;RLV_VARIANTSIGNIFICANCE=[C|MSH6]Reported pathogenic;RLV_VARIANTSIGNIFICANCESOURCE=[C|MSH6]ClinVar;RLV_VARIANTSIGNIFICANCEJUSTIFICATION=[C|MSH6]NM_000179.2(MSH6):c.261-1G>C MSH6 Likely pathogenic;RLV_VARIANTCOMPOUNDHET=[C|MSH6]NA;RLV_VARIANTGROUP=[C|MSH6]NA
2	179394686	TTN:c.106531+1G>A	C	T	.	.	CADD_SCALED=25.7;RLV_PRESENT=FALSE
2	179449797	TTN:c.64672+2T>C	A	G	.	.	CADD_SCALED=23.1;RLV_PRESENT=FALSE
2	179452242	TTN:c.63793+1G>A	C	T	.	.	RLV_PRESENT=FALSE
